top of page
  • Writer's pictureANPDF

Zevra Therapeutics Media Release | December 27, 2023

Zevra Therapeutics Announces Resubmission Of Arimoclomol New Drug Application To The U.S. Food And Drug Administration


Read the full statement from Zevra Therapeutics here:



Here is a summary of the article:

 

To join our fight, as well as fund vital research for a cure, support the Australian NPC Disease Foundation in its goals of "Research. Cure. Persevere."


Ways to support NP-C in Australia:

13 views0 comments
bottom of page